Skip to main content
. 2019 May 27;11(5):247. doi: 10.3390/pharmaceutics11050247

Figure 7.

Figure 7

Anticancer activity of HBIM/DOX and HBIM/DOX/PEI in (A) HeLa cells and (B) A549 cells.